Advertisement

Current Diabetes Reports

, 18:140 | Cite as

Non-Diabetic Hyperglycemia in the Pediatric Age: Why, How, and When to Treat?

  • Valentina Fattorusso
  • Rosa Nugnes
  • Alberto Casertano
  • Giuliana Valerio
  • Enza MozzilloEmail author
  • Adriana Franzese
Pediatric Type 2 and Monogenic Diabetes (PS Zeitler and O Pinhas-Hamiel, Section Editors)
  • 111 Downloads
Part of the following topical collections:
  1. Topical Collection on Pediatric Type 2 and Monogenic Diabetes

Abstract

Purpose of review

Non-diabetic hyperglycemia (NDHY) is a pathological condition that is not yet well known. The aim of this review is to examine approaches for management of this condition.

Recent findings

While it is well known that persistent hyperglycemia in diabetes affects immune response and risk for diabetes-related micro- and macrovascular complications, little is known about the biological effects of transient NDHY, particularly in the pediatric age group.

Summary

Stress HY (SHY) is typically defined as blood glucose > 8.33 mmol/L (150 mg/dL) during physical stress, resolving spontaneously after dissipation of acute illness in patients without known diabetes. Based on the literature and clinical practice, two situations can be classified: (1) SHY1, which occurs during severe and prolonged illness and under serious life-threatening conditions, mainly in emergency situations and in resuscitation areas; and (2) SHY2, which occurs during acute illness, mainly in non-life-threatening conditions. Furthermore, (NDHY) among pediatric patients can be induced by drugs; the most frequent conditions are secondary to (1) steroid therapy and (2) antineoplastic/immunosuppressive therapy.

Keywords

Non-diabetic hyperglycemia Stress hyperglycemia Drug-induced hyperglycemia Management 

Notes

Compliance with Ethical Standards

Conflict of Interest

Valentina Fattorusso, Rosa Nugnes, Alberto Casertano, Giuliana Valerio, Enza Mozzillo, and Adriana Franzese declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Srinivasan V, Spinella PC, Drott HR, et al. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med. 2004;5(4):329–36.CrossRefPubMedGoogle Scholar
  2. 2.
    Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373:1798–807.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr. 2005;146(1):30–4.CrossRefPubMedGoogle Scholar
  4. 4.
    Wintergerst KA, Buckingham B, Gandrud L, et al. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics. 2006;118(1):173–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Yung M, Wilkins B, Norton L, Slater A. Paediatric Study Group; Australian and New Zealand Intensive Care Society. Glucose control, organ failure, and mortality in pediatric intensive care. Pediatr Crit Care Med. 2008;9(2):147–52.  https://doi.org/10.1097/PCC.0b013e3181668c22.CrossRefPubMedGoogle Scholar
  6. 6.
    Hirshberg E, Larsen G, Van Duker H. Alterations in glucose homeostasis in the pediatric intensive care unit: Hyperglycemia and glucose variability are associated with increased mortality and morbidity. Pediatr Crit Care Med. 2008;9(4):361–6.  https://doi.org/10.1097/PCC.0b013e318172d401.CrossRefPubMedGoogle Scholar
  7. 7.
    Preissig CM, Rigby MR. Pediatric critical illness hyperglycemia: risk factors associated with development and severity of hyperglycemia in critically ill children. J Pediatr. 2009;155(5):734–9.  https://doi.org/10.1016/j.jpeds.2009.05.007.CrossRefPubMedGoogle Scholar
  8. 8.
    Ognibene KL, Vawdrey DK, Biagas KV. The association of age, illness severity, and glycemic status in a pediatric intensive care unit. Pediatr Crit Care Med. 2011;12(6):e386–90.  https://doi.org/10.1097/PCC.0b013e3182192c53.CrossRefPubMedGoogle Scholar
  9. 9.
    Gore DC, Chinkes D, Heggers J, et al. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma. 2001;51(3):540–4.PubMedGoogle Scholar
  10. 10.
    Cochran A, Scaife ER, Hansen KW, et al. Hyperglycemia and outcomes from pediatric traumatic brain injury. J Trauma. 2003;55(6):1035–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Branco RG, Garcia PC, Piva JP, et al. Glucose level and risk of mortality in pediatric septic shock. Pediatr Crit Care Med. 2005;6(4):470–2.CrossRefPubMedGoogle Scholar
  12. 12.
    Yates AR, Dyke PC Taeed R, et al. Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patients. Pediatr Crit Care Med. 2006;7(4):351–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Day KM, Haub N, Betts H, et al. Hyperglycemia is associated with morbidity in critically ill children with meningococcal sepsis. Pediatr Crit Care Med. 2008;9(6):636–40.  https://doi.org/10.1097/PCC.0b013e31818d350b.CrossRefPubMedGoogle Scholar
  14. 14.
    •• Vanhorebeek GJ, Van den Berghe G. Critical Care Management of Stress-Induced Hyperglycemia. Current Diabetes Reports. 2018;18:17.  https://doi.org/10.1007/s11892-018-0988-2. This paper compares studies debating the efficacy and safety of tight glycemic control in critically ill patients and proposes strategies for safer glucose control.
  15. 15.
    Moradi S, Keshavarzi A, Tabatabaee SM. Is stress hyperglycemia a predicting factor of developing diabetes in future? Exp Clin Endocrinol Diabetes. 2015;123(10):614–6.  https://doi.org/10.1055/s-0035-1559719.CrossRefPubMedGoogle Scholar
  16. 16.
    Valerio G, Franzese A, Carlin E, et al. High prevalence of stress hyperglycaemia in children with febrile seizures and traumatic injuries. Acta Paediatr. 2001;90(6):618–22.CrossRefPubMedGoogle Scholar
  17. 17.
    Mobaireek KF, Alsheri A, Alsadoun A, Alsamari A, Alashhab A, Alrumaih M, et al. Hyperglycemia in children hospitalized with acute asthma. Adv Exp Med Biol. 2018.  https://doi.org/10.1007/5584_2018_152.
  18. 18.
    Weiss SL, Alexander J, Agus M. Extreme stress hyperglycemia during acute illness in a pediatric emergency department. Pediatr Emerg Care. 2010;26(9):626–32.  https://doi.org/10.1097/PEC.0b013e3181ef0488. CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Vlasselaers D, Milants I, Desmet L. Intensive insulin therapy for patients in pediatric intensive care: a prospective, randomized controlled study. Lancet. 2009;373(9663):547–56.  https://doi.org/10.1016/S0140-6736(09)60044-1.CrossRefPubMedGoogle Scholar
  20. 20.
    Agus MS, Steil GM, Wypij D, et al. Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med. 2012;367(13):1208–19.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Jeschke MG, Kraft R, Emdad F, et al. Glucose control in severely thermally injured pediatric patients: what glucose range should be the target? Ann Surg. 2010;252(3):521–7.  https://doi.org/10.1097/SLA.0b013e3181f2774c.CrossRefPubMedGoogle Scholar
  22. 22.
    Srinivasan V, Agus MS. Tight glucose control in critically ill children—a systematic review and meta-analysis. Pediatr Diabetes. 2014;15(2):75–83.CrossRefPubMedGoogle Scholar
  23. 23.
    Pham TN, Warren AJ, Phan HH, et al. Impact of tight glycemic control in severely burned children. J Trauma. 2005;59(5):1148–54.CrossRefPubMedGoogle Scholar
  24. 24.
    Macrae D, Grieve R, Allen E, et al. A randomized trial of hyperglycemic control in pediatric intensive care. N Engl J Med. 2014;370(2):107–18.  https://doi.org/10.1056/NEJMoa1302564.CrossRefPubMedGoogle Scholar
  25. 25.
    Agus MS, Wypij D, Hirshberg EL, et al. Tight Glycemic Control in Critically ill Children. N Engl J Med. 2017;376(8):729–41.  https://doi.org/10.1056/NEJMoa1612348.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Chikani UN, Ibekwe MU, Oguonu T, et al. Steroid-induced impairment of glucose tolerance: prevalence among pediatric patients on long-term steroid use in Nigeria. Pediatr Diabetes. 2017;18(8):942–6.  https://doi.org/10.1111/pedi.12514.CrossRefPubMedGoogle Scholar
  27. 27.
    Tamez-Perez HE, Quintanilla-Flores DL, Rodriguez-Gutierrez R, et al. Steroid hyperglycemia: prevalence, early detection and therapeutic recommendations: a narrative review. World J Diabetes. 2015;6(8):1073–81.  https://doi.org/10.4239/wjd.v6.i8.1073.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Van Raalte DH, Kwa KA, Van Genugten RE, et al. Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance? Metabolism. 2013;62(4):568–77.  https://doi.org/10.1016/j.metabol.2012.10.007.CrossRefPubMedGoogle Scholar
  29. 29.
    Donihi AC, Raval D, Saul M, et al. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract. 2006;12(4):358–62.CrossRefPubMedGoogle Scholar
  30. 30.
    Liu XX, Zhu XM, Miao Q, et al. Hyperglycemia induced by glucocorticoids in nondiabetic patients: a meta-analysis. Ann Nutr Metab. 2014;65(4):324–32.  https://doi.org/10.1159/000365892.CrossRefPubMedGoogle Scholar
  31. 31.
    Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009;15(5):469–74.  https://doi.org/10.4158/EP08331.RAR.CrossRefPubMedGoogle Scholar
  32. 32.
    Prokai A, Fekete A, Kis E, et al. Post-transplant diabetes mellitus in children following renal transplantation. Pediatr Transplant. 2008;12(6):643–9.CrossRefPubMedGoogle Scholar
  33. 33.
    • Arians G, De Jong S, Gietema J, et al. Cancer-drug induced insulin resistance: innocent bystander or unusual suspect. Cancer Treat Rev. 2015;41(4):376–84.  https://doi.org/10.1016/j.ctrv.2015.02.007. This paper discusses the pathogenesis of hyperglycemia induced by antineoplastic drugs and suggests treatment strategies. CrossRefGoogle Scholar
  34. 34.
    Gatzioura I, Papakonstantinou E, Dimitriadou M, et al. Glucose Levels Before the Onset of Asparaginase Predicts Transient Hyperglycemia in Children with Acute Lymphoblastic Leukemia. Pediatr Blood Cancer. 2016;63:1181–4.CrossRefPubMedGoogle Scholar
  35. 35.
    Yoshida H, Imamura T, Saito AM, et al. Protracted administration of l-asparaginase in maintenance phase is the risk factor for hyperglycemia in older patients with pediatric acute lymphoblastic leukemia. PLoS One. 2015;10:e0136428.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Di Cosmo N, Vajiro P, Debray D, et al. Normal β-cell function in post-liver transplantation diabetes treated with tacrolimus. Diabetes Care. 2004;27(7):1837–8.CrossRefPubMedGoogle Scholar
  37. 37.
    Srinivasan V. Stress Hyperglycemia in Pediatric Critical Illness: The Intensive Care Unit Adds to the Stress! J Diabetes Sci Technol. 2012;6(1):37–47.  https://doi.org/10.1177/193229681200600106.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Preissig CM, Rigby MR. Hyperglycaemia results from beta-cell dysfunction in critically ill children with respiratory and cardiovascular failure: a prospective observational study. Crit Care. 2009;13(1):R27.  https://doi.org/10.1186/cc7732.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Kwon S, Hermayer KL. Glucocorticoid-induced hyperglycemia. Am J Med Sci. 2013;345(4):274–7.  https://doi.org/10.1097/MAJ.0b013e31828a6a01.CrossRefPubMedGoogle Scholar
  40. 40.
    Dhital SM, Shenker Y, Meredith M, et al. A retrospective study comparing neutral protamine Hagedorn insulin with glargine as basal therapy in prednisone-associated diabetes mellitus in hospitalized patients. Endocr Pract. 2012;18(5):712–9.  https://doi.org/10.4158/EP11371.OR.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Oron T, Gat-Yablonski G, Lazar L, et al. Stress hyperglycemia: a sign of familial diabetes in children. Pediatrics. 2011;128(6):e1614–7.  https://doi.org/10.1542/peds.2010-3193.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Valentina Fattorusso
    • 1
  • Rosa Nugnes
    • 1
  • Alberto Casertano
    • 1
  • Giuliana Valerio
    • 2
  • Enza Mozzillo
    • 1
    Email author
  • Adriana Franzese
    • 1
  1. 1.Department of Translational Medical Science (DISMET), Section of PediatricsUniversity of Naples Federico IINaplesItaly
  2. 2.Department of Movement Sciences and WellbeingParthenope UniversityNaplesItaly

Personalised recommendations